PROMETA DRUG PROTOCOL DOES NOT HELP TREAT METHAMPHETAMINE DEPENDENCE
The US company which owns and markets the controversial PROMETA proprietary combination of drugs for
methamphetamine dependence funded a rigorous trial by independent researchers; the result was a
no-better-than-placebo verdict, another negative in the search for drugs to counter stimulant
dependence.
To view this entry click on the link below or paste it in to your web browser address box, being
sure to enter the whole address:
http://findings.org.uk/count/downloads/download.php?file=Ling_W_11.txt
**************************************
Sent by Drug and Alcohol Findings (http://findings.org.uk) to alert you to site updates and recent
UK-relevant evaluations and reviews of drug/alcohol interventions. Managed by DrugScope, Alcohol
Concern and the National Addiction Centre. Supported by Alcohol Research UK and the J Paul Getty Jr
Charitable Trust.
You have received this message via another mailing list. To receive these messages directly sign up
at:
http://findings.org.uk/index.php#signUp
|